This seems like another overreaction. Looking to grab a few more at $1.5 and 1.4 range. Profits up debt down. Sales and profit growth is 5 percent beats inflation. Anyways solution? Buyback increase earnings per share in a low growth environment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025